Ochsenkühn T - Search Results

1

Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.

Török HP, Glas J, Endres I, Tonenchi L, Teshome MY, Wetzke M, Klein W, Lohse P, Ochsenkühn T, Folwaczny M, Göke B, Folwaczny C, Müller-Myhsok B, Brand S. Török HP, et al. Among authors: ochsenkuhn t. Am J Gastroenterol. 2009 Jul;104(7):1723-33. doi: 10.1038/ajg.2009.184. Epub 2009 May 19. Am J Gastroenterol. 2009. PMID: 19455129

2

Increased risk of 'high-risk' colorectal adenomas in overweight men.

Bayerdörffer E, Mannes GA, Ochsenkühn T, Köpcke W, Wiebecke B, Paumgartner G. Bayerdörffer E, et al. Among authors: ochsenkuhn t. Gastroenterology. 1993 Jan;104(1):137-44. doi: 10.1016/0016-5085(93)90845-4. Gastroenterology. 1993. PMID: 8419236

3

Detection of colonic dysplasia by light-induced fluorescence endoscopy: a pilot study.

Brand S, Stepp H, Ochsenkühn T, Baumgartner R, Baretton G, Holl J, von Ritter C, Paumgartner G, Sackmann M. Brand S, et al. Among authors: ochsenkuhn t. Int J Colorectal Dis. 1999 Feb;14(1):63-8. doi: 10.1007/s003840050186. Int J Colorectal Dis. 1999. PMID: 10207734 Clinical Trial.

4

Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.

Ochsenkühn T, Göke B, Sackmann M. Ochsenkühn T, et al. Am J Gastroenterol. 2002 Aug;97(8):2022-5. doi: 10.1111/j.1572-0241.2002.05918.x. Am J Gastroenterol. 2002. PMID: 12190171

5

[Pathogenesis and epidemiology of sigmoid diverticulosis].

Ochsenkühn T, Göke B. Ochsenkühn T, et al. Chirurg. 2002 Jul;73(7):665-9. doi: 10.1007/s00104-002-0495-4. Chirurg. 2002. PMID: 12242973 German.

6

[Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].

Ochsenkühn T, Sackmann M, Göke B. Ochsenkühn T, et al. Radiologe. 2003 Jan;43(1):1-8. doi: 10.1007/s00117-002-0844-9. Radiologe. 2003. PMID: 12552369 Review. German.

7

[MRI in Crohn's disease after transduodenal contrast administration using negative oral MRI contrast media].

Holzknecht N, Helmberger T, Herrmann K, Ochsenkühn T, Göke B, Reiser M. Holzknecht N, et al. Among authors: ochsenkuhn t. Radiologe. 2003 Jan;43(1):43-50. doi: 10.1007/s00117-002-0841-z. Radiologe. 2003. PMID: 12552374 German.

8

Does ursodeoxycholic acid change the proliferation of the colorectal mucosa?. A randomized, placebo-controlled study.

Ochsenkühn T, Marsteller I, Hay U, Diebold J, Paumgartner G, Göke B, Sackmann M. Ochsenkühn T, et al. Digestion. 2003;68(4):209-16. doi: 10.1159/000075927. Epub 2003 Dec 30. Digestion. 2003. PMID: 14707397 Clinical Trial.

9

Safety aspects of infliximab in inflammatory bowel disease patients. A retrospective cohort study in 100 patients of a German University Hospital.

Seiderer J, Göke B, Ochsenkühn T. Seiderer J, et al. Among authors: ochsenkuhn t. Digestion. 2004;70(1):3-9. doi: 10.1159/000080075. Epub 2004 Aug 3. Digestion. 2004. PMID: 15297773

10

Infliximab for acute, not steroid-refractory ulcerative colitis: a randomized pilot study.

Ochsenkühn T, Sackmann M, Göke B. Ochsenkühn T, et al. Eur J Gastroenterol Hepatol. 2004 Nov;16(11):1167-71. doi: 10.1097/00042737-200411000-00014. Eur J Gastroenterol Hepatol. 2004. PMID: 15489577 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters